Glemanserin (MDL11939) is a potent and selective antagonist for serotonin receptor 5-HT2A (Ki=2.89, 0.54 and 2.5 nM for rat 5-HT2A, rabbit 5-HT2A and human 5-HT2A, respectively).
性状
Solid
体内研究(In Vivo)
Glemanserin (MDL11939) suppresses the induced increase in locomotor activity, behavioral sensitization and withdrawal symptoms in male mice.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.